Experiment 1164988
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | GOCKERMAN,JP: BARTOLUCCI,AA: NELSON,MO: SILBERMAN,H: VELEZ-GARCIA,E: STEIN,R:. (1986). PHASE II EVALUATION OF ETOPOSIDE IN REFRACTORY MULTIPLE MYELOMA: A SOUTHEASTERN CANCER STUDY GROUP TRIAL.. 70(6) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN THIS PHASE II TRIAL, 48 PATIENTS WITH REFRACTORY MULTIPLE MYELOMA WERE TREATED WITH ETOPOSIDE, DAYS 1-5, EVERY 3 WEEKS FOR AT LEAST 4 COMPLETE CYCLES. TWO PARTIAL RESPONSES AND 7 WITH STABLE DISEASE WERE SEEN. TOXICITY INCLUDED NEUTROPENIA, THROMBOCYTOPENIA, INFECTION AND STOMATITIS. |
| Dose amount | 40.50 MG |
| Number | 1 |
| Qualitative result | EQUIVOCAL |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |